25
Participants
Start Date
November 6, 2020
Primary Completion Date
July 19, 2021
Study Completion Date
July 19, 2021
BMS-986259
Specified dose on specified days
Placebo
Specified dose on specified days
Local Institution - 0009, Ciudad de Buenos Aires
Local Institution - 0007, Alberdi
Local Institution - 0028, Córdoba
Local Institution - 0025, Córdoba
Local Institution - 0011, Athens
Local Institution - 0020, Prague
Local Institution, Jerusalem
Local Institution, Petah Tikva
Local Institution - 0014, Tel Aviv
Local Institution - 0010, Córdoba
Local Institution, Buenos Aires
Nemocnice Slany-Interna - kardiologicka ambulance, Slaný
Local Institution - 0022, Athens
Local Institution - 0034, Bialystok
Local Institution - 0030, Wrocaw
Local Institution - 0027, Wroclaw
Local Institution, Edinburgh
Local Institution, Swindon
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY